Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors

Bone Marrow Transplantation

Volumn 21, Issue SUPPL. 3, 1998, Pages

  Ringden O ^a   Hagglund H ^a   Runde, V ^b   Basu, O ^b   Kroschinsky, F ^c   Stockschlader M ^c   Potter, M N ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Dept of Haematology ^*  (Germany)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Allogeneic; Bone marrow transplantation; Graft versus host disease; Leukaemia; Peripheral blood progenitor cells; Unrelated donors

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ASPARTYLGLYCOSAMINURIA; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONFERENCE PAPER; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LEUKOCYTE TRANSFUSION; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA;

BONE MARROW TRANSPLANTATION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, MYELOID, CHRONIC; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 2642709175     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Lowry PA, Tabara IA. Peripheral hematopoietic stem cell transplantation: current concepts. Exp Hematol 1993; 20: 937-942.
2. Sheridan WP, Glenn Begley C, Juttner CA et al. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-644.
3. Russel NH, Hunter AE. Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 1994; 13: 353-355.
4. Dreger P, Suttorp M, Haferlach T et al. Allogeneic granulocyte colony-stimulating factor-mobilised peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404-1407.
5. Ringdén O, Nilsson B. Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy. Transplantation 1985; 40: 39-44.
6. Ringdén O, Lönnqvist B, Hägglund H et al. Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease (letter). Bone Marrow Transplant 1995; 16: 856-857.
7. + cells from an HLA-identical unrelated donor. Bone Marrow Transplant 1995; 16: 719-722.
8. Ringdén O, Potter MN, Oakhill A et al. Transplantation of peripheral blood progenitor cells from unrelated donors. Bone Marrow Transplant 1996; 17 (Suppl 2): S62-S64.
9. Oakhill A, Pamphilon DH, Potter MN et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukemia in second complete remission. Br J Haematol 1996; 94: 574-578.
10. Ringdén O, Remberger M, Persson U et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995; 15: 619-625.
11. Storb R, Deeg HJ, Farewell K et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986; 68: 119-125.
12. Ringdén O, Horowitz MM, Sondel P et al. Methotrexate, cyclosporine or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukaemia? Blood 1993; 81: 1094-1101.
13. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
14. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
15. Becker PS, Wagle M, Matous S et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 1997; 3: 45-49.
16. Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609-613.
17. + cell dose predicts survival, post-transplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996; 88: 3223-3229.
18. Storb R, Prentice RL, Sullivan KM et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 1983; 98: 461-466.
19. Ringdén O, Paulin T, Lönnqvist B, Nilsson B. An analysis of factors predisposing for chronic graft-versus-host disease. Exp Hematol 1985; 13: 1062-1067.
20. Kolb H-J, Schattenberg A, Goldman J et al for the European Group for Blood and Marrow Transplantation Working Party on Chronic Leukemia. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
21. Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukemia. Results of a randomised multicentre trial. (in press).